These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 15077314

  • 21. Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis.
    Jinnin M, Makino T, Kajihara I, Honda N, Makino K, Ogata A, Ihn H.
    Br J Dermatol; 2010 Apr; 162(4):751-8. PubMed ID: 19886888
    [Abstract] [Full Text] [Related]

  • 22. Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis.
    Allanore Y, Borderie D, Lemaréchal H, Cherruau B, Ekindjian OG, Kahan A.
    J Rheumatol; 2003 Jan; 30(1):68-73. PubMed ID: 12508392
    [Abstract] [Full Text] [Related]

  • 23. Quantification of circulating endothelial progenitor cells in systemic sclerosis: a direct comparison of protocols.
    Kuwana M, Okazaki Y.
    Ann Rheum Dis; 2012 Apr; 71(4):617-20. PubMed ID: 22258488
    [Abstract] [Full Text] [Related]

  • 24. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
    Sato S, Komura K, Hasegawa M, Fujimoto M, Takehara K.
    J Rheumatol; 2001 Nov; 28(11):2460-5. PubMed ID: 11708419
    [Abstract] [Full Text] [Related]

  • 25. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
    Vancheeswaran R, Magoulas T, Efrat G, Wheeler-Jones C, Olsen I, Penny R, Black CM.
    J Rheumatol; 1994 Oct; 21(10):1838-44. PubMed ID: 7837147
    [Abstract] [Full Text] [Related]

  • 26. Circulating endothelial cells: a novel marker of endothelial damage.
    Erdbruegger U, Haubitz M, Woywodt A.
    Clin Chim Acta; 2006 Nov; 373(1-2):17-26. PubMed ID: 16836991
    [Abstract] [Full Text] [Related]

  • 27. Comprehensive investigation of disease-specific short peptides in sera from patients with systemic sclerosis: complement C3f-des-arginine, detected predominantly in systemic sclerosis sera, enhances proliferation of vascular endothelial cells.
    Xiang Y, Matsui T, Matsuo K, Shimada K, Tohma S, Nakamura H, Masuko K, Yudoh K, Nishioka K, Kato T.
    Arthritis Rheum; 2007 Jun; 56(6):2018-30. PubMed ID: 17530642
    [Abstract] [Full Text] [Related]

  • 28. Vascular damage and lack of angiogenesis in systemic sclerosis skin.
    Konttinen YT, Mackiewicz Z, Ruuttila P, Ceponis A, Sukura A, Povilenaite D, Hukkanen M, Virtanen I.
    Clin Rheumatol; 2003 Sep; 22(3):196-202. PubMed ID: 14505210
    [Abstract] [Full Text] [Related]

  • 29. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
    Makin AJ, Blann AD, Chung NA, Silverman SH, Lip GY.
    Eur Heart J; 2004 Mar; 25(5):371-6. PubMed ID: 15033248
    [Abstract] [Full Text] [Related]

  • 30. Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease.
    Moroni G, Del Papa N, Moronetti LM, Vitali C, Maglione W, Comina DP, Urgnani F, Sandri S, Ponticelli C, Cortelezzi A.
    Kidney Int; 2005 Aug; 68(2):562-8. PubMed ID: 16014033
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Evaluation of renal vascular lesions using circulating endothelial cells in patients with lupus nephritis.
    Yao G, Liu ZH, Zheng C, Zhang X, Chen H, Zeng C, Li LS.
    Rheumatology (Oxford); 2008 Apr; 47(4):432-6. PubMed ID: 18292121
    [Abstract] [Full Text] [Related]

  • 33. Circulating endothelial cells and endothelial progenitors as surrogate biomarkers in vascular dysfunction.
    Wu H, Chen H, Hu PC.
    Clin Lab; 2007 Apr; 53(5-6):285-95. PubMed ID: 17605403
    [Abstract] [Full Text] [Related]

  • 34. Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes.
    Boos CJ, Soor SK, Kang D, Lip GY.
    Eur Heart J; 2007 May; 28(9):1092-101. PubMed ID: 17449878
    [Abstract] [Full Text] [Related]

  • 35. Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
    Yanaba K, Komura K, Kodera M, Matsushita T, Hasegawa M, Takehara K, Sato S.
    Ann Rheum Dis; 2006 Jan; 65(1):124-6. PubMed ID: 16344498
    [Abstract] [Full Text] [Related]

  • 36. Plasma D-dimer concentration in patients with systemic sclerosis.
    Marie I, Borg JY, Hellot MF, Levesque H.
    Br J Dermatol; 2008 Feb; 158(2):392-5. PubMed ID: 18028493
    [Abstract] [Full Text] [Related]

  • 37. Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis.
    Timár O, Soltész P, Szamosi S, Dér H, Szántó S, Szekanecz Z, Szücs G.
    J Rheumatol; 2008 Jul; 35(7):1329-33. PubMed ID: 18484693
    [Abstract] [Full Text] [Related]

  • 38. Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis.
    Ogawa F, Shimizu K, Muroi E, Hara T, Hasegawa M, Takehara K, Sato S.
    Rheumatology (Oxford); 2006 Jul; 45(7):815-8. PubMed ID: 16449367
    [Abstract] [Full Text] [Related]

  • 39. Circulating endothelial cells: markers of vascular dysfunction.
    Goon PK, Boos CJ, Lip GY.
    Clin Lab; 2005 Jul; 51(9-10):531-8. PubMed ID: 16285476
    [Abstract] [Full Text] [Related]

  • 40. Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients.
    Sato LT, Kayser C, Andrade LE.
    Acta Reumatol Port; 2009 Jul; 34(2A):219-27. PubMed ID: 19474777
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.